title: Targeting interleukin-5 in refractory and relapsing Churg-Strauss syndrome.
authors: Frank
authors: F
authors: Moosig
authors: Wolfgang Ludwig
authors: WL
authors: Gross
authors: Kristina
authors: K
authors: Herrmann
authors: Jan Phillip
authors: JP
authors: Bremer
authors: Bernhard
authors: B
authors: Hellmich
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D015267:Churg-Strauss Syndrome / Q000188:drug therapy* / Q000276:immunology; D015536:Down-Regulation; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015848:Interleukin-5 / Q000276:immunology*; D008727:Methotrexate / Q000627:therapeutic use; D012074:Remission Induction
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D015848:Interleukin-5; C434107:mepolizumab; D008727:Methotrexate